[go: up one dir, main page]

Collins et al., 1977 - Google Patents

Comparison of activity of herpes virus inhibitors

Collins et al., 1977

Document ID
5029335406344371496
Author
Collins P
Bauer D
Publication year
Publication venue
Journal of Antimicrobial Chemotherapy

External Links

Snippet

Comparisons of the anti-herpes virus activity of idoxuridine, cytarabine, vidarabine, trifluorothymidine and ara-DAP were made in vitro and in vivo. Although the activity of these compounds was substantiated in vivo, the test methods were insufficiently sensitive for …
Continue reading at academic.oup.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof

Similar Documents

Publication Publication Date Title
US4757088A (en) Antiviral pharmaceutical preparations and methods for their use
DE2728685C2 (en) Medicines to fight viral infections
Kern et al. Treatment of experimental herpesvirus infections with phosphonoformate and some comparisons with phosphonoacetate
Collins et al. Comparison of activity of herpes virus inhibitors
Bauer A history of the discovery and clinical application of antiviral drugs
US5021437A (en) 2-acetylpyridine 5-[(2-chloroanilino)thiocarbonyl]thiocarbonohydrazone compound and salts thereof
Buchanan et al. Vidarabine (Vira-A®): Pharmacology and clinical experience
Ayisi et al. Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with adenine arabinoside, 5-ethyldeoxyuridine, 5-iododeoxyuridine, and phosphonoacetic acid against herpes simplex virus types 1 and 2
Thieulent et al. Identification of antiviral compounds against equid herpesvirus-1 using real-time cell assay screening: Efficacy of decitabine and valganciclovir alone or in combination
JP2724711B2 (en) Pharmaceutical products
Soike et al. Investigation of antiviral activity of 1-β-D-arabinofuranosylthymine (ara-T) and 1-β-D-arabinofuranosyl-E-5-(2-bromovinyl) uracil (BV-ara-U) in monkeys infected with simian varicella virus
KR100243455B1 (en) Topical dosage compositions for promoting the healing of herpes lesions
EP2289520A1 (en) Use of acetylsalicylic acid for the prophylaxis and/or treatment of influenza virus infection.
BAR-ILAN et al. Ocular penetration and hypotensive activity of the topically applied carbonic anhydrase inhibitor L-645,151
DE3875016T2 (en) THERAPEUTIC FOR TREATING AIDS.
Maudgal et al. Efficacy of (S)-HPMPA against thymidine kinase-deficient herpes simplex virus-keratitis.
Park et al. Prophylaxis of herpetic keratoconjunctivitis with interferon inducers: Preliminary observations
DE1617659C3 (en) Interferon-forming drug and its use
DE3885090T2 (en) COMPOSITION AND METHOD FOR TREATING HEPATITIC VIRUS INFECTIONS USING 1- (2'-DEOXY-2'-FLUORO-BETA-D-ARABINOFURANOSYL) -5-ETHYLURACIL.
Shiraki et al. Caffeine inhibits paresthesia induced by herpes simplex virus through action on primary sensory neurons in rats
Pancic et al. Antiviral activity of Win 41258-3, a pyrazole compound, against herpes simplex virus in mouse genital infection and in guinea pig skin infection
Whitley et al. Herpes zoster: focus on treatment in older adults
JPH07106980B2 (en) Therapeutic agent for diseases caused by herpes virus
Burkhardt et al. Combined chemotherapy of cutaneous herpes simplex infection of the guinea pig
DE60132581T2 (en) MEDICAMENT FOR THE TREATMENT OF DISORDERS CAUSED BY PARASITIC PROTOCOLS